Apollo Hospitals Enterprise Limited

NSE:APOLLOHOSP.NS

7189.5 (INR) • At close August 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202520242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 217,940190,592166,124.5145,362104,680111,71595,939.2782,233.272,549.0660,855.8851,784.5343,842.2137,687.0531,475.2526,053.520,264.65116,142.05212,147.7189,494.5397,695.8976,607.466
Cost of Revenue 148,367155,70785,742.375,73556,84254,98946,608.6440,326.6135,954.0430,557.7225,811.9821,501.2918,558.3315,595.5213,886.4210,725.9868,728.0076,529.95,098.1174,088.4083,327.567
Gross Profit 69,57334,88580,382.269,62747,83856,72649,330.6341,906.5936,595.0230,298.1625,972.5522,340.9219,128.7215,879.7312,167.089,538.6667,414.0465,617.8184,396.4213,607.4893,279.899
Gross Profit Ratio 0.3190.1830.4840.4790.4570.5080.5140.510.5040.4980.5020.510.5080.5050.4670.4710.4590.4620.4630.4690.496
Reseach & Development Expenses 023421111000000000000000000
General & Administrative Expenses 018,94714,92912,1917,1838,0497,385.36,098.821,346.06939.52643.48511.67500.242,442.543,827.52,342.181,732.7991,246.3060115.37195.505
Selling & Marketing Expenses 06,5806,3973,6481,9982,2711,838.841,742.751,965.681,167.1932.11,065.04832.69862.210378.551427.434309.491099.33784.25
SG&A 46,93025,52721,32615,8399,18110,3209,224.147,841.573,311.742,106.621,575.581,576.711,332.933,304.753,827.52,720.7322,160.2331,555.7980214.707179.754
Other Expenses 00903.416118511089.3799.128,955.3117.5513.9617.73301.74-24.993,308.64,213.7363,430.4142,452.3563,034.9982,437.7522,225.03
Operating Expenses 46,93073,49566,038.553,74341,95147,01542,159.0537,372.7232,218.0924,692.3220,445.4517,081.3914,299.7411,124.757,136.16,934.4685,590.6474,008.1533,034.9982,652.462,404.784
Operating Income 22,64317,07314,49215,8845,6729,7136,7424,533.874,376.935,605.845,527.15,259.534,828.984,754.985,030.982,604.1981,823.3981,609.6641,361.423955.029875.115
Operating Income Ratio 0.1040.090.0870.1090.0540.0870.070.0550.060.0920.1070.120.1280.1510.1930.1290.1130.1330.1430.1240.132
Total Other Income Expenses Net -2,582-3,448-3,206-30,749-3,716-3,748-3,005.59-2,818.24-2,156.77-1,221.05-972.97-1,192.45-838.2-806.25-1,232.15-627.759-475.556-419.949-153.077-281.668-347.482
Income Before Tax 20,06113,62511,007.715,7812,2076,6003,735.411,714.622,220.774,163.684,554.134,067.083,990.783,259.732,613.181,976.4391,343.7171,189.7151,224.272673.361527.633
Income Before Tax Ratio 0.0920.0710.0660.1090.0210.0590.0390.0210.0310.0680.0880.0930.1060.1040.10.0980.0830.0980.1290.0870.08
Income Tax Expense 5,3404,4552,5624,7708472,2521,733.731,119.05909.611,002.181,300.021,017.621,050.371,149.6872.95676.145489.938374.118325.578238.398203.651
Net Income 14,4598,9868,19110,5561,5044,5492,360.461,174.182,209.913,234.873,305.513,063.12,956.992,122.471,755.461,336.593909.697854.452898.695481.368356.307
Net Income Ratio 0.0660.0470.0490.0730.0140.0410.0250.0140.030.0530.0640.070.0780.0670.0670.0660.0560.070.0950.0630.054
EPS 100.5562.556.9773.4210.7432.6916.978.4415.8816.9924.4322.7722.0816.8314.8411.158.67.059.365.414.73
EPS Diluted 100.5562.556.9773.4210.7432.6916.978.4415.8816.9924.4322.7721.8816.314.3711.18.36.779.215.34.73
EBITDA 32,22124,02021,39325,56812,42418,11910,9458,249.437,645.527,601.817,384.936,780.916,305.155,421.494,339.163,328.012,434.6792,088.5831,656.9041,295.2951,186.491
EBITDA Ratio 0.1480.1260.1290.1760.1190.1620.1140.10.1050.1250.1430.1550.1670.1720.1670.1640.1510.1720.1750.1680.18